CD4+CD25+FoxP3+ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease

Clinical Immunology

Volumn 123, Issue 1, 2007, Pages 50-59

  Chen, Xinchun ^a,b,c   Zhou, Boping ^a,c   Li, Meizhong ^a,c   Deng, Qunyi ^a,c   Wu, Xueqiong ^d   Le, Xiaohua ^a,c   Wu, Chi ^a,c   Larmonier, Nicolas ^b   Zhang, Wei ^a   Zhang, Hongmei ^a,c   Wang, Huosheng ^a,c   Katsanis, Emmanuel ^b  

^a Shenzhen Donghu Hospital   (China)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c GUANGDONG MEDICAL UNIVERSITY   (China)

^d 309TH HOSPITAL OF PLA   (China)

Author keywords

CD4+CD25+FoxP3+ regulatory T cells; Mycobacterium tuberculosis; Pulmonary tuberculosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; BACTERIAL IMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MALE; MYCOBACTERIUM TUBERCULOSIS; PLEURA FLUID; PRIORITY JOURNAL;

ADULT; ANTITUBERCULAR AGENTS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PLEURAL EFFUSION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TUBERCULOSIS, PLEURAL; TUBERCULOSIS, PULMONARY;

EID: 33947253487     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.11.009     Document Type: Article

References (43)

1. Dye C. Global epidemiology of tuberculosis. Lancet. 367 9514 (2006) 938-940
2. Hirsch C.S., et al. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J. Infect. Dis. 180 6 (1999) 2069-2073
3. Jo E.K., Park J.K., and Dockrell H.M. Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr. Opin. Infect. Dis. 16 3 (2003) 205-210
4. Lienhardt C., et al. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur. J. Immunol. 32 6 (2002) 1605-1613
5. Ferrer J. Pleural tuberculosis. Eur. Respir. J. 10 4 (1997) 942-947
6. Jalapathy K.V., Prabha C., and Das S.D. Correlates of protective immune response in tuberculous pleuritis. FEMS Immunol. Med. Microbiol. 40 2 (2004) 139-145
7. Arruda S., et al. Cell-mediated immune responses and cytotoxicity to mycobacterial antigens in patients with tuberculous pleurisy in Brazil. Acta Trop. 71 1 (1998) 1-15
8. Flynn J.L., and Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 19 (2001) 93-129
9. Stenger S., and Modlin R.L. T cell mediated immunity to Mycobacterium tuberculosis. Curr. Opin. Microbiol. 2 1 (1999) 89-93
10. + T lymphocyte subpopulation in tuberculous pleuritis. J. Immunol. 142 4 (1989) 1114-1119
11. Sakaguchi S., et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155 3 (1995) 1151-1164
12. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6 4 (2005) 345-352
13. O'Garra A., and Vieira P. Regulatory T cells and mechanisms of immune system control. Nat. Med. 10 8 (2004) 801-805
14. Belkaid Y., and Rouse B.T. Natural regulatory T cells in infectious disease. Nat. Immunol. 6 4 (2005) 353-360
15. Fontenot J.D., and Rudensky A.Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6 4 (2005) 331-337
16. + regulatory T cells at the single-cell level. Eur. J. Immunol. 35 6 (2005) 1681-1691
17. + regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 98 5 (2003) 1089-1099
18. Wolf D., et al. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin. Cancer Res. 11 23 (2005) 8326-8331
19. Larmonier N., et al. Tumor-derived CD4(+)CD25 (+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10. Cancer Immunol. Immunother. 56 1 (2007) 48-59
20. + regulatory T cells control Leishmania major persistence and immunity. Nature 420 6915 (2002) 502-507
21. Mills K.H. Regulatory T cells: friend or foe in immunity to infection?. Nat. Rev., Immunol. 4 11 (2004) 841-855
22. high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect. Immun. 71 4 (2003) 1755-1762
23. Stoop J.N., et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 41 4 (2005) 771-778
24. + regulatory T cells to immune status in HIV-infected patients. Aids 19 9 (2005) 879-886
25. Boussiotis V.A., et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J. Clin. Invest. 105 9 (2000) 1317-1325
26. Guyot-Revol V., et al. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am. J. Respir. Crit. Care Med. 173 7 (2006) 803-810
27. + T cells in regulation of the immune response during human tuberculosis. Clin. Exp. Immunol. 144 1 (2006) 25-34
28. Rook G.A., Dheda K., and Zumla A. Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not. Tuberculosis (Edinb.) 86 3-4 (2006) 152-162
29. Rook G.A., Dheda K., and Zumla A. Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat. Rev., Immunol. 5 8 (2005) 661-667
30. Maloy K.J., and Powrie F. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2 9 (2001) 816-822
31. + T cell clones and peripheral blood T cells. J. Immunol. 149 7 (1992) 2378-2384
32. de Waal Malefyt R., et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174 4 (1991) 915-924
33. Asadullah K., Sterry W., and Volk H.D. Interleukin-10 therapy-review of a new approach. Pharmacol. Rev. 55 2 (2003) 241-269
34. + Tregs: limiting collateral damage. J. Clin. Invest. 114 10 (2004) 1372-1378
35. + T cells. J. Immunol. 160 7 (1998) 3188-3193
36. + regulatory T cells in peripheral blood mononuclear cells from healthy subjects stimulated with Leishmania guyanensis. Infect. Immun. 73 9 (2005) 5908-5914
37. + natural regulatory T cells are specific for microbial antigens. J. Exp. Med. 203 3 (2006) 777-788
38. Chieppa M., et al. Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. J. Immunol. 171 9 (2003) 4552-4560
39. Sutmuller R.P., et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 116 2 (2006) 485-494
40. + regulatory T cells. Proc. Natl. Acad. Sci. U. S. A. 103 18 (2006) 7048-7053
41. Gehring A.J., et al. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J. Immunol. 173 4 (2004) 2660-2668
42. Quesniaux V.J., et al. Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J. Immunol. 172 7 (2004) 4425-4434
43. Nakamura K., Kitani A., and Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194 5 (2001) 629-644